Skip to main content
. 2022 Jan 26;27(3):819. doi: 10.3390/molecules27030819

Figure 6.

Figure 6

Timeline in the development of EGFR TKIs during the last two decades. Green boxes above the line indicates the drugs approved by FDA, while the black boxes below the lines indicates the phase I clinical trial of the TKIs.